Explore more publications!

Sci-Tech Portal St. Lucia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Portal St. Lucia.

Press releases published on November 26, 2025

Nano Labs Launches “NBNB Program” to Advance RWA Infrastructure and Compliance Ecosystem on BNB Chain
Scilex Holding Company Announces Closing of Previously Announced Second Tranche Investment in Datavault AI Inc., Completing Its Two-Tranche Equity Financing in Datavault AI Inc.
Datavault AI Announces Closing of the Second Tranche of Scilex Holding Company’s Previously Announced Equity Financing
Fennec Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference
VTC Rises: Game Publisher Secures Industry Icon with Major Awards
Redefining Cloud-to-Cloud Data Routing with Cavli Hubble™ Messaging Service
Tangram Therapeutics Submits Clinical Trial Application for Phase 1/2 Study of TGM-312, a Novel Investigational RNAi MASH Candidate
Huize Holding Limited to Hold Annual General Meeting on December 17, 2025
NimbleEdge Contributes to Microsoft’s Foundry Local for Android, Unlocking Next-Gen On-Device AI for Android
Galapagos Receives Transparency Notifications from Bank of America
Galapagos ontvangt transparantieverklaringen van Bank of America
Valneva Announces Positive Final Phase 2 Results for Lyme Disease Vaccine Candidate
Valneva annonce des résultats finaux positifs de Phase 2 pour son candidat vaccin contre la maladie de Lyme
Denodo als führender Anbieter von Softwareplattformen für die Datenintegration im IDC MarketScape ausgezeichnet
Denodo nommé leader des plateformes logicielles d’intégration de données par IDC MarketScape
Denodo צוינה כמובילה ב-IDC MarketScape עבור פלטפורמות תוכנה לשילוב נתונים
Denodo Dinobatkan sebagai Peneraju dalam IDC MarketScape bagi Platform Perisian Integrasi Data
TTEC Expands Operations in Egypt Following Global Offshoring Summit Engagement
ZenaDrone de ZenaTech establece una oficina en el área de Washington, D.C. fortaleciendo las oportunidades de ingresos en defensa de EE. UU. y acceso al mercado del gobierno federal
Teva erhält Zulassung der Europäischen Kommission für PONLIMSI® (Denosumab), ein Biosimilar zu Prolia®, und DEGEVMA® (Denosumab), ein Biosimilar zu Xgeva®

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions